-
1دورية أكاديمية
المؤلفون: Freiberger, Sandra N., Holzmann, David, Morand, Grégoire B., Hüllner, Martin, Levesque, Mitchell P., Dummer, Reinhard, Koelzer, Viktor H., Rupp, Niels J.
المصدر: Journal of Cancer Research & Clinical Oncology; Aug2023, Vol. 149 Issue 9, p5645-5653, 9p
مصطلحات موضوعية: TUMOR antigens, TESTIS tumors, GENE expression, NUCLEOTIDE sequencing, IMMUNE checkpoint inhibitors, MELANOMA
-
2
المؤلفون: Fässler, Mirjam, Diem, Stefan, Mangana, Joanna, Hasan Ali, Omar, Berner, Fiamma, Bomze, David, Ring, Sandra, Niederer, Rebekka, Del Carmen Gil Cruz, Cristina, Pérez Shibayama, Christian Ivan, Krolik, Michal, Siano, Marco, Joerger, Markus, Recher, Mike, Risch, Lorenz, Güsewell, Sabine, Risch, Martin, Speiser, Daniel E, Ludewig, Burkhard, Levesque, Mitchell P, Dummer, Reinhard, Flatz, Lukas
المساهمون: University of Zurich, Flatz, Lukas
المصدر: Fässler, Mirjam; Diem, Stefan; Mangana, Joanna; Hasan Ali, Omar; Berner, Fiamma; Bomze, David; Ring, Sandra; Niederer, Rebekka; Del Carmen Gil Cruz, Cristina; Pérez Shibayama, Christian Ivan; Krolik, Michal; Siano, Marco; Joerger, Markus; Recher, Mike; Risch, Lorenz; Güsewell, Sabine; Risch, Martin; Speiser, Daniel E; Ludewig, Burkhard; Levesque, Mitchell P; ... (2019). Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients. Journal for immunotherapy of cancer, 7(1), p. 50. BioMed Central 10.1186/s40425-019-0523-2 <http://dx.doi.org/10.1186/s40425-019-0523-2Test>
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Journal for Immunotherapy of Cancer
Journal for immunotherapy of cancer, vol. 7, no. 1, pp. 50مصطلحات موضوعية: Male, Antibodies, Neoplasm, 610 Medicine & health, Metastatic melanoma, Antibodies, Monoclonal, Humanized, lcsh:RC254-282, Antibodies, TRP2, TRP1, Antineoplastic Agents, Immunological, Humans, NY-ESO-1, 1306 Cancer Research, Immune response, Melanoma, Aged, Aged, 80 and over, 2403 Immunology, 10177 Dermatology Clinic, Biomarker, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Ipilimumab, 3004 Pharmacology, Nivolumab, gp100, 1313 Molecular Medicine, Immunoglobulin G, 2723 Immunology and Allergy, Melanocyte differentiation antigens, MART1, 2730 Oncology, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Neoplasm/blood, Antineoplastic Agents, Immunological/therapeutic use, Biomarkers, Female, Immunoglobulin G/blood, Ipilimumab/therapeutic use, Melanoma/blood, Melanoma/drug therapy, Melanoma/immunology, Nivolumab/therapeutic use, Cancer/testis antigens, Checkpoint inhibitors, Research Article
وصف الملف: application/pdf; document.pdf - application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c0383a55b6649492b2f23f1522734b4Test
https://boris.unibe.ch/174992/1/50.full.pdfTest -
3دورية أكاديمية
المؤلفون: Dummer, Reinhard, Ramelyte, Egle, Schindler, Sabrina, Thürigen, Olaf, Levesque, Mitchell P., Koelblinger, Peter
المصدر: OncoImmunology; 2017, Vol. 6 Issue 8, pN.PAG-N.PAG, 1p
مصطلحات موضوعية: MELANOMA, IMMUNE response, ANTINEOPLASTIC agents
-
4دورية أكاديمية
المؤلفون: Peri, Aviyah1, Greenstein, Erez2, Alon, Michal1, Pai, Joy A.3, Dingjan, Tamir4, Reich-Zeliger, Shlomit2, Barnea, Eilon5, Barbolin, Chaya1, Levy, Ronen1, Arnedo-Pac, Claudia6, Kalaora, Shelly1, Dassa, Bareket7, Feldmesser, Ester7, Shang, Ping8, Greenberg, Polina1, Levin, Yishai9, Benedek, Gil10, Levesque, Mitchell P.11, Adams, David J.12, Lotem, Michal13
المصدر: Journal of Clinical Investigation. 10/15/2021, Vol. 131 Issue 20, p1-20. 20p.
مصطلحات موضوعية: *IMMUNE response, *T cell receptors, *TUMOR-infiltrating immune cells, *PEPTIDES, *T cells